A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Completed · Phase 2

Conditions studied: Non-Hodgkin's Lymphoma

In brief

For patients with relapsed and refractory aggressive non-Hodgkin's lymphoma

Key facts

Study ID

NCT00038545

Run by

M.D. Anderson Cancer Center

People needed

25

Starts

2001-05-18

Expected to finish

2004-04-27

Last updated by the study team

2018-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.